Skip to content

LoFric® 40314Recalls & reported problems

Wellspect AB · Single Use Urinary Catheter LoFric Nelaton 8" 14FR · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07392532135132), received between Aug 19, 2022 and Aug 19, 2022 — classified as 1 malfunction.

The most frequently reported specific device problem is “Sharp Edges” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Sharp Edges1

Patient problems

  • Hemorrhage/Blood Loss/Bleeding1
  • Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionAug 19, 2022Sharp Edges; Sharp Edges

    THE INCIDENT CONCERN USAGE OF LOFRIC NELATON INTERMITTENT URINARY CATHETER WHICH OCCURRED IN AUSTRIA. PATIENT CLAIMED THAT SHE HAD USED LOFRIC 20 CM CATHETER NELATON (STRAIGHT TIP) FR 14 AND EXPERIENCED THAT THE CATHETER TIP WAS CATHETER TIP WAS ROUGH AND WAS CONSEQUENTLY INJURED. THE PATIENT CONSULTED MEDICAL CARE BECAUSE OF SORENESS AND BLEEDING. NO FURTHER INFORMATION HAS BEEN RECEIVED.

    Patient problems: Hemorrhage/Blood Loss/Bleeding; Pain

    MAUDE report 15257615 ↗

Other CATHETER, STRAIGHT devices

All CATHETER, STRAIGHT devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page